Brief: HLB Life Science says conversion of 4th series convertible bonds into shares
Nov 23 (Reuters) - HLB Life Science Co Ltd 067630.KQ :
* Says 3.77 billion won worth of its 4th series convertible
bonds
have been converted into 643,336 shares of the co, at 5,860
won/share
* Says listing date of new shares is Dec. 6
Source text in Korean: https://goo.gl/5t1e8e
Further company coverage: 067630.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on HLB Life Science
See all newsBrief: Hlb Life Science To Divest 36 Billion Won Worth Of Shares In Affiliate Hlb Cell
Moody's announces completion of a periodic review of ratings of EnergySolutions, LLC
Moody's affirms EnergySolutions' ratings with senior secured and CFR at B3; outlook to stable
Moody's announces completion of a periodic review of ratings of EnergySolutions, LLC
Moody's downgrades EnergySolutions' CFR to B3; outlook is negative